Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, on
behalf of its wholly owned subsidiary Cubist Pharmaceuticals, Inc.,
today announced that, in connection with the completion of the
acquisition of Cubist by Merck, Cubist has commenced a tender offer (the
Convertible Notes Tender Offer) to
repurchase, at the option of each holder, any and all of its outstanding
2.50% Convertible Senior Notes due 2017 (the 2017
Convertible Notes), 1.125% Convertible Senior Notes due 2018
(the